In an article in OncLive experts specializing in multiple myeloma mention what they believe to be the top studies presented at the 2021 ASH annual meeting and how their findings have the potential to change clinical practice.
iStopMM study changes the definition of multiple myeloma precursor condition
Recently an interview appeared in Nordic Life Science with Thorir Long author of Defining new reference intervals for serum free light chains in individuals with